Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
50 participants
INTERVENTIONAL
2016-08-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy
NCT03393572
Role of Magnesium Sulphate as an Adjuvant to Bupivacaine in U.S Guided Quadratus Lumborum Block in Lower Abdominal Cancer Surgeries
NCT06301789
TAP Block With Magnesium Sulfate Added to Local Anesthetic in Abdominal Hysterectomy
NCT02930707
Intraperitoneal Magnesium Sulphate and Bupivacaine Versus Intravenous Analgesia in Laparoscopic Surgeries in Pediatrics
NCT04651556
Postoperative Analgesia in Laparoscopic Gynecological Surgeries
NCT06491485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intrathecal bupivacaine + Mg sulfate
intrathecal bupivacaine 15 mg + intrathecal Mg sulfate 50 mg. in gynecologic laparoscopic surgeries.
intrathecal Mg sulfate.
intrathecal Mg sulfate 50 mg.
intrathecal bupivacaine 15 mg.
intrathecal bupivacaine 15 mg.
intrathecal bupivacaine
intrathecal bupivacaine 15 mg in gynecologic laparoscopic surgeries.
intrathecal bupivacaine 15 mg.
intrathecal bupivacaine 15 mg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intrathecal Mg sulfate.
intrathecal Mg sulfate 50 mg.
intrathecal bupivacaine 15 mg.
intrathecal bupivacaine 15 mg.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* more than 18 years.
* undergoing elective gynecologic laparoscopic surgeries.
Exclusion Criteria
* contraindication to spinal anesthesia.
* Significant cardiac, liver or renal dysfunction.
* Inability to informed consent
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
khaled salah mohamed
lecturer of anaesthesia and ICU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asiut university hospital
Asiut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
intrathecal Mg in gyne. lap.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.